Stockholders’ Equity (Deficit) (Details) - USD ($)		1 Months Ended	3 Months Ended	9 Months Ended
	Jun. 29, 2020	Oct. 31, 2017	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 10, 2020	Jul. 02, 2020	Dec. 31, 2019
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred stock, shares authorized			3,000,000	3,000,000				3,000,000
Preferred stock, par value (in Dollars per share)			$ 0.001	$ 0.001				$ 0.001
Common stock, shares authorized			27,000,000	27,000,000				27,000,000
Common stock, par value (in Dollars per share)			$ 0.001	$ 0.001				$ 0.001
Common stock issued			330,916	330,916		2,400,000
Services and recognized expense (in Dollars)				$ 1,312,930	$ 82,000
Sale of common stock				3,740,753	106,475
Exercise of warrants and received (in Dollars)				$ 210,546
Common stock issued for preferred shares				1,250,000
Preferred stock shares				1,250,000
Settlement of accounts payable Shares				146,818
Settlement of debt (in Dollars)			$ 62,500	$ 62,500
Common stock issued			11,823,545	11,823,545				3,915,900
Common stock issued for services					20,500
Cash received (in Dollars)					$ 370,177
Shares for liabilities					100,803
Exchange for liabilities (in Dollars)					$ 201,605
Reverse stock split, description	On June 29, 2020, the Company effectuated a 1-for-2 reverse stock split of its issued and outstanding shares of common stock by filing a certificate of amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware.
Total grant fair value (in Dollars)					2,495,556
Warrants issued and vesting (in Dollars)				$ 223,398	947,190
Compensation expense related to options issued and vesting (in Dollars)					$ 2,513,826
General and administrative expenses (in Dollars)				$ 148,472
Weighted average vesting term				189 days
Warrants exercised				3,740,753
Proceeds from exercised (in Dollars)				$ 210,546
Warrants issued (in Dollars)			$ 60,000
Vesting period			These warrants have an exercise price of $5.00, a term of five years, and become exercisable beginning on March 1, 2021.
Exercise price (in Dollars per share)			$ 5.00
Warrant term			5 years
Equity Option [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Company granted				7,500	700,000
Exercise prices (in Dollars per share)				$ 11.00	$ 4.00
Total grant fair value (in Dollars)				$ 27,799
Equity Option [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Warrants issued and vesting (in Dollars)				$ 27,799
IPO [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock issued							1,226,668
Common stock issued			1,226,668	1,226,668
September 2020 Offering [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock issued			1,150,000	1,150,000
2017 Equity Incentive Plan [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Share issued for stock based compensation		2,500,000
Warrant [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock issued			3,740,753	3,740,753